This descriptive study was used to identify problems with assessment and documentation of chemotherapy-induced peripheral neuropathy (CIPN). It was also used to justify implementing a standardized patient questionnaire as part of initial and ongoing patient assessments. A convenient sample of 30 patients was included in this study. At hospital admission or upon arrival at the clinic, patients were randomly selected to answer the European Organization for Research and Treatment of Cancer's CIPN20 patient questionnaire.
More than 90% of participants complained of varying degrees of numbness and tingling; 50% complained of symptoms that interfered with activities of daily living. About half of the patients complained of pain associated with their neuropathy. Despite these findings, on the patient questionnaire, only 3 of the patients' charts had nursing documentation supporting the presence of CIPN. Findings supported the need for uniform assessment to assist in managing limitations caused by the development of CIPN.
|Advisor:||Kawar, Lina N.|
|School:||California State University, Long Beach|
|School Location:||United States -- California|
|Source:||MAI 50/03M, Masters Abstracts International|
Copyright in each Dissertation and Thesis is retained by the author. All Rights Reserved
The supplemental file or files you are about to download were provided to ProQuest by the author as part of a
dissertation or thesis. The supplemental files are provided "AS IS" without warranty. ProQuest is not responsible for the
content, format or impact on the supplemental file(s) on our system. in some cases, the file type may be unknown or
may be a .exe file. We recommend caution as you open such files.
Copyright of the original materials contained in the supplemental file is retained by the author and your access to the
supplemental files is subject to the ProQuest Terms and Conditions of use.
Depending on the size of the file(s) you are downloading, the system may take some time to download them. Please be